A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...
A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...
A rigorous new study finds that a single dose of LSD can ease a person's anxiety for months. NPR's Jon Hamilton reports that the study shows how research on psychedelics is entering the mainstream.
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
“While prior research has documented the benefits of combining LSD with psychotherapy to alleviate anxiety associated with life-threatening conditions, this groundbreaking study is the first to show ...
A new study finds that a single dose of LSD can ease a person's anxiety for months. This could give legitimacy to research on a range of psychedelics. A rigorous new study finds that a single dose of ...
(CNN) — A clinical trial’s encouraging results won an LSD formulation approval from the US Food and Drug Administration as a breakthrough therapy for generalized anxiety disorder, Mind Medicine Inc.
“While prior research has documented the benefits of combining LSD with psychotherapy to alleviate anxiety associated with life-threatening conditions, this groundbreaking study is the first to show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results